Systemic sclerosis, also known as scleroderma, is a rare and complex autoimmune
connective-tissue disease. Once considered an untreatable and unpredictable condition …

Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

Pulmonary hypertension (PH) is highly heterogeneous and despite treatment advances it
remains a life-shortening condition. There have been significant advances in imaging …

Pulmonary hypertension (PH) commonly affects patients with systemic sclerosis (SSc) and is
associated with significant morbidity and increased mortality. PH is a heterogenous …

Background: Patients with systemic sclerosis (SSc)–associated pulmonary arterial
hypertension (PAH) have a far worse prognosis than those with idiopathic PAH (IPAH). In …

The objective of this study was to evaluate the incidence of pulmonary hypertension (PH)
and determining factors in patients with systemic sclerosis (SSc) and a diffusing capacity of …

Background Pulmonary arterial hypertension (PAH) is a leading cause of death in patients
with systemic sclerosis (SSc). The purpose of this study was to assess long-term outcomes …

Systemic sclerosis (SSc) is associated with high mortality owing to internal organ
complications, and lung disease is the leading cause of SSc-associated death. The most …

The prognostic importance of follow-up haemodynamics and the validity of multidimensional
risk assessment are not well established for systemic sclerosis (SSc)-associated pulmonary …

Pulmonary hypertension (PH) is defined by the presence of a mean pulmonary arterial
pressure> 20 mmHg. Current guidelines describe five groups of PH with shared …